Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of...
Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext...
Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc...
Lyon, France, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Valneva Reports Strong Business Performance in First Nine Months Company Increases Financial Guidance for Full Year 2016 Nine Months...
LYON, France, March 26, 2015 (GLOBE NEWSWIRE) -- The vaccine was developed by the Chemo-Sero Therapeutic Research Institute (Kaketsuken) in collaboration with GlaxoSmithKline using Valneva's...
LYON, France, March 20, 2015 (GLOBE NEWSWIRE) -- Valneva Reports Annual Results 2014 The company announces a significant improvement to its EBITDA and a strong reduction of its net loss...
LYON, France, March 17, 2015 (GLOBE NEWSWIRE) -- Valneva announces signing of an exclusive license agreement on EB66® Cell Line for Human and Veterinary Vaccines in People's Republic of...
WALTHAM, Mass., April 16, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced new appointments to its board of directors. Current board member, Gino Santini, has...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 156 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
| 260 | 0 | 0 | 0.145 | 0.145 | 0.145 | 0 | 0 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
